Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
July 22, 2020 Off

Veeva Extends Remote Meeting Capabilities to Zoom and Microsoft Teams

By BusinessWire

Life sciences companies and doctors can leverage Veeva CRM Engage Meeting across the online meeting platforms they’re already using PLEASANTON,…

July 22, 2020 Off

Veeva Extends Remote Meeting Capabilities to Zoom and Microsoft Teams

By BusinessWire

Life sciences companies and doctors can leverage Veeva CRM Engage Meeting across the online meeting platforms they’re already using PLEASANTON,…

July 22, 2020 Off

Syneos Health Strengthens Commercial Services with Veeva Commercial Cloud

By BusinessWire

Leading biopharmaceutical services company brings together multichannel customer engagement, data, and content to speed commercial launches Addition of Veeva OpenData…

July 22, 2020 Off

Syneos Health Strengthens Commercial Services with Veeva Commercial Cloud

By BusinessWire

Leading biopharmaceutical services company brings together multichannel customer engagement, data, and content to speed commercial launches Addition of Veeva OpenData…

July 22, 2020 Off

Liva Healthcare Supports National Weight Loss Service With LloydsPharmacy

By BusinessWire

LONDON–(BUSINESS WIRE)–Liva Healthcare is providing vital lifestyle and weight loss support in collaboration with LloydsPharmacy to help tackle the UK’s…

July 22, 2020 Off

Liva Healthcare Supports National Weight Loss Service With LloydsPharmacy

By BusinessWire

LONDON–(BUSINESS WIRE)–Liva Healthcare is providing vital lifestyle and weight loss support in collaboration with LloydsPharmacy to help tackle the UK’s…

July 22, 2020 Off

Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures

By BusinessWire

Investment addresses today’s challenge to efficiently transport next-generation therapeutics such as cell and gene therapy to the target and unlock…

July 22, 2020 Off

Vesigen Therapeutics Launches with USD 28.5 Million Series A Investment Led by Leaps by Bayer and Morningside Ventures

By BusinessWire

Investment addresses today’s challenge to efficiently transport next-generation therapeutics such as cell and gene therapy to the target and unlock…

July 22, 2020 Off

A Versatile Vessel for Next-gen Therapeutics: Harvard’s ARMMs Technology to Be Commercialized by Vesigen Therapeutics

By BusinessWire

  CAMBRIDGE, Mass.–(BUSINESS WIRE)–Harvard University’s Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today…

July 22, 2020 Off

A Versatile Vessel for Next-gen Therapeutics: Harvard’s ARMMs Technology to Be Commercialized by Vesigen Therapeutics

By BusinessWire

  CAMBRIDGE, Mass.–(BUSINESS WIRE)–Harvard University’s Office of Technology Development (OTD) and the Harvard T.H. Chan School of Public Health today…

Posts pagination

Previous 1 … 4,721 4,722 4,723 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine